We are live on ! Find out more
OIM

Oracle Investment Management Portfolio holdings

AUM $168M
1-Year Est. Return 42.86%
This Fund
S&P 500
This Quarter Est. Return
-8.98%
1 Year Est. Return
+42.86%
3 Year Est. Return
+864.89%
5 Year Est. Return
+1,153.35%
10 Year Est. Return
+22,228.86%
AUM
$176M
AUM Growth
-$153M
Cap. Flow
-$123M
Cap. Flow %
-69.91%
Top 10 Hldgs %
94.7%
Holding
34
New
7
Increased
7
Reduced
6
Closed
10

Top Buys

Rank Stock Value
1
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$9.67M
2
PACB icon
Pacific Biosciences
PACB
+$3.38M
3
BHVN icon
Biohaven
BHVN
+$2.91M
4
WGS icon
GeneDx Holdings
WGS
+$2.52M
5
IBRX icon
ImmunityBio
IBRX
+$1.44M

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$181M
2
MRNA icon
Moderna
MRNA
+$12.8M
3
CFRX
ContraFect Corporation
CFRX
+$6.05M
4
OPK icon
Opko Health
OPK
+$5.08M
5
TQQQ icon
ProShares UltraPro QQQ
TQQQ
+$2.92M

Sector Composition

Rank Sector Weight
1 Healthcare 98.06%
2 Industrials 0.15%
3 Energy 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRNA icon
26
Moderna
MRNA
$23.6B
– –
-89,700
Closed -$12.8M
PFE icon
27
CALL
Pfizer
PFE
$153B
– –
-500,000
Closed -$1.51M
SLNO
28
DELISTED
Soleno Therapeutics
SLNO
– –
-142,133
Closed -$394K
VTNR
29
CALL
DELISTED
Vertex Energy, Inc
VTNR
– –
-150,300
Closed -$49K
VTNR
30
DELISTED
Vertex Energy, Inc
VTNR
– –
-56,800
Closed -$598K
PNT
31
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
– –
-129,810
Closed -$884K
CDAK
32
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
– –
-463,998
Closed -$1.34M
CFRX
33
DELISTED
ContraFect Corporation
CFRX
– –
-24,615
Closed -$6.05M
BHVN
34
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
– –
-1,240,932
Closed -$181M
1
2

Similar funds

EECFX
EnCap Energy Capital Fund XII Houston, Texas $169M AUM
PW
Pandora Wealth Oakbrook Terrace, Illinois $165M AUM 18.5% 1-Year Est. Return
PWA
Principia Wealth Advisory Dallas, Texas $160M AUM 37.01% 1-Year Est. Return
AIMU
Allianz Investment Management US Minneapolis, Minnesota $160M AUM 4.75% 1-Year Est. Return
HIA
Harvest Investment Advisors Tallahassee, Florida $176M AUM
ACA
AG Campbell Advisory Baltimore, Maryland $158M AUM
CWA
Clearview Wealth Advisors Salem, Oregon $158M AUM 14.25% 1-Year Est. Return
SW
Schulz Wealth Mansfield, Texas $156M AUM 13.29% 1-Year Est. Return

Oracle Investment Management's Q3 2022 Portfolio in Review

As of Q3 2022, Oracle Investment Management held 34 positions worth $176M, down 47% from $329M the previous quarter. Its ten largest holdings account for 95% of the portfolio.

Oracle Investment Management withdrew a net $123M in Q3 2022, closing 10 positions and reducing 6 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $181M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, up from 98% a quarter earlier, followed by Industrials and Energy.

Against the trend, Oracle Investment Management opened a new position in Biohaven worth $59.3M.

  • Oracle Investment Management's largest Q3 2022 buy was Biohaven: 401,221 shares worth $59.3M.
  • Oracle Investment Management added most to Mirati Therapeutics, Inc. Common Stock in Q3 2022, an estimated $9.67M increase.
  • Oracle Investment Management's biggest Q3 2022 reduction was Opko Health, cutting an estimated $5.08M.
  • Oracle Investment Management fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q3 2022, selling an estimated $181M.
  • Oracle Investment Management's ten largest holdings make up 95% of its $176M portfolio in Q3 2022.
  • Oracle Investment Management opened 7 new positions and closed 10 in Q3 2022.
  • Oracle Investment Management's portfolio value fell 47% quarter-over-quarter to $176M.

Based on Oracle Investment Management's 13F filing for Q3 2022, filed 14 Nov 2022.